Open AccessBRAF Inhibitor Vemurafenib Induces Clinical Responses in Hairy Cell Leukemia
Author(s) -
Mark Fuerst
Publication year - 2014
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000441984.27014.23
Subject(s) - vemurafenib , medicine , cancer research , mapk/erk pathway , purine analogue , hairy cell leukemia , v600e , targeted therapy , dabrafenib , cancer , oncology , melanoma , kinase , leukemia , immunology , mutation , purine , biology , metastatic melanoma , biochemistry , gene , enzyme , microbiology and biotechnology